Skip to content
NYSE · REAL ESTATE INVESTMENT TRUSTS · LARGE CAP

American Healthcare Reit, Inc. AHR

11 fiscal years on record · USD · FY2025 reported · SEC filings only
$2.3B
▲ 9.1% YoY
$69.8M
$-590.0M
▼ 609.8% YoY

Slide the table for earlier years · "·" marks a figure not available in our data for that year.

In brief

What this company does

American Healthcare REIT, Inc. acquires, owns and operates a diversified portfolio of clinical healthcare real estate properties, focusing primarily on senior housing, skilled nursing facilities, outpatient medical buildings and other healthcare-related facilities. As of December 31, 2025, the company had approximately 121 employees, including 74 in Accounting and Finance, 17 in Asset Management, 10 in Investments, five in Information Technology and four in Legal. As of December 31, 2025, the company operated through four reportable business segments: ISHC, OM, SHOP and triple-net leased properties. As of December 31, 2025, the company owned and/or operated 147 integrated senior health campuses, which allow residents to age in place by providing independent living, assisted living, memory care, skilled nursing and certain ancillary services within a single campus setting. As of December 31, 2025, the company owned 74 outpatient medical buildings that it leases to third parties. As of December 31, 2025, the company owned and operated 97 senior housing and skilled nursing facilities in its SHOP segment. As of December 31, 2025, the company owned six skilled nursing facilities within its triple-net leased properties segment that it leases to third parties. The company elected to be taxed as a REIT for U.S. federal income tax purposes commencing with its taxable year ended December 31, 2016.

Written from the business description in American Healthcare REIT, Inc.'s annual report to the U.S. Securities and Exchange Commission, filed 27 February 2026. Every sentence was checked against that document before publication.

Growth

USD 2.3B
Revenue, FY2025 · full 11-year series below
Revenue $B Net income $B
FY2025 · Revenue 2.3 · Net income 0.1
1B2B
20152018202120242025
Compound annual growth
+17.0%
+16.2%
+100.3%
+31.6%
+26.7%
3 yrs
5 yrs
10 yrs
15 yrs

Revenue compounded at +16.2% a year over the five years to FY2025 — but profit grew faster: net income at +100.3%.

Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.

Profitability

3 cents
of every revenue dollar became profit
Operating margin Net margin
FY2025 · Operating 18.4% · Net 3.1%
10%20%-50%-100%-150%
201520202025
ROE
FY2025 · ROE 2.5%
1%2%-5%-10%
201520202025
Three returns, three denominators.
Return on capital employedNot available: we don't have total assets or current liabilities for this period.

Each USD of equity produced 3 cents of profit this year.

Cash & shareholders

USD 163.5M
returned in FY2025 · dividends + net buybacks
Free cash flow $M
FY2025 · FCF -590.0
100.0M200.0M-250.0M-500.0M
201520202025
Net buybacks $B Dividends $B
FY2025 · Dividends 0.2 · Net buybacks -1.2
0.1B0.2B-0.5B-1.0BDividendsNet buybacks
201520172019202120232025

USD 163.5M in dividends — 234% of the year's profit, so the payout drew on cash built up earlier.

Total assetsUSD 5.4B
EquityUSD 3.3B
CashUSD 114.8M
Gross debtUSD 966.9M
Net debtUSD 852.1M

Net debt stands at 26% of equity.

The 11-year record

11 fiscal years
Every figure from documents filed with the SEC · USD

EPS, diluted, dividend per share and shares outstanding are shown without shading, and a vertical line marks the year the share count changed — the series crosses a large, unexplained change in share count, so the years on either side are not on a comparable scale.

row low → row highnegative—not applicable◌not available in our data
AHR, 11-year financial record
Metric 20252024202320222021202020192018201720162015
Revenue $B2.32.11.91.41.11.11.10.10.00.00.0
Operating income $B0.40.40.30.30.20.20.2−0.00.0−0.00.0
EBITDA $B0.60.50.50.50.30.30.30.00.0−0.00.0
Income tax $B−0.00.00.00.00.0−0.00.00.00.00.0◌
Net income $B0.1−0.0−0.1−0.1−0.00.0−0.0−0.00.0−0.00.0
Free cash flow $B−0.60.10.10.1−0.10.20.1−0.3−0.3−0.10.0
EPS, diluted $0.42−0.29−1.08−1.24−0.950.05−0.03−0.150.02−1.750.00
Dividend / sh $1.001.001.001.600.690.860.650.600.600.40◌
Payout %234−320−107−63−481248−1261−1671183−10—
ROE %2.5−2.1−5.4−5.5−3.90.3−0.8−2.40.2−11.80.0
Shares out B◌◌◌◌◌0.18◌◌◌◌0.00

Slide the table for earlier years. "—" not applicable · "◌" not available in our data.

More in this sector

Other companies filing in the same sector

Provenance

Company facts, as filed

How we verify · 0 failures in 32 reconciliationsAUDITED

Reconciled in 11 of the 11 fiscal years we could check. Nine checks were skipped: cost of revenue is not tagged before 2016. Eight checks were skipped: the balance sheet is not tagged before 2015. Eight checks were skipped: EPS is not tagged before 2015.

EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidityCurrency consistency0 failures
ActivityReal Estate Investment Trusts
Listed onNYSE
Incorporated inMaryland
Fiscal year endsDecember 31
Data on record since2015

Share this section

Download image